E
Exact Sciences
Finding Cancer Early When It's More Treatable
Madison, WI
6,000+
About Exact Sciences
Industry:
Cancer Diagnostics
Founded:
1995
Founders:
Stanley Lapidus, Anthony Shuber
Status:
Public (NASDAQ: EXAS)
Funding & Growth
Total Raised:
$3B+
Valuation:
$10B+ market cap
Stage:
Public
Key Investors:
Public markets
✓ Pros
- • Market leader in Cologuard
- • Strong revenue and growth
- • Mission-driven culture
- • Multi-cancer early detection pipeline
- • Good work-life balance
✗ Cons
- • Madison, WI location (not major hub)
- • Large company processes
- • Competition from liquid biopsy
- • Sales-driven organization